Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,051 | -193,878 | -126,729 | -64,788 | 6,083 |
| Depreciation Amortization | 2,978 | 15,615 | 11,746 | 5,433 | 2,884 |
| Accounts receivable | 18,249 | -7,661 | -7,100 | -790 | 1,572 |
| Accounts payable and accrued liabilities | 349 | -2,284 | -423 | -1,117 | -3,651 |
| Other Working Capital | -1,502 | 11,780 | 13,579 | 23,950 | 16,412 |
| Other Operating Activity | -6,209 | 52,465 | 37,254 | 21,599 | 10,329 |
| Operating Cash Flow | $-76,186 | $-123,963 | $-71,673 | $-15,713 | $33,629 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 71,823 | -13,454 | -51,500 | -94,278 | 45,767 |
| PPE Investments | -1,235 | -2,414 | -1,906 | -1,415 | -1,024 |
| Investing Cash Flow | $70,588 | $-15,868 | $-53,406 | $-95,693 | $44,743 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 794 | 1,366 | 1,276 | 535 | 457 |
| Other Financing Activity | -14,433 | 115,405 | 125,079 | 132,903 | -6,251 |
| Financing Cash Flow | $-13,639 | $116,771 | $126,355 | $133,438 | $-5,794 |
| Beginning Cash Position | 36,496 | 59,556 | 59,556 | 59,556 | 59,556 |
| End Cash Position | 17,259 | 36,496 | 60,832 | 81,588 | 132,134 |
| Net Cash Flow | $-19,237 | $-23,060 | $1,276 | $22,032 | $72,578 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,186 | -123,963 | -71,673 | -15,713 | 33,629 |
| Capital Expenditure | -1,235 | -2,414 | -1,906 | -1,415 | -1,024 |
| Free Cash Flow | -77,421 | -126,377 | -73,579 | -17,128 | 32,605 |